期刊文献+

HPLC法测定大鼠血浆中乙醛的含量

HPLC determination of acetaldehyde in rat plasma
原文传递
导出
摘要 目的:建立检测大鼠血浆中乙醛(ACH)浓度的HPLC方法。方法:选择正丁醛-2,4-二硝基苯肼(DNPH)为内标,采用ZORBAX Eclipse XDB-C18(250 mm×4.6 mm,5μm)色谱柱,以甲醇-乙腈-水(25∶35∶40,v/v/v)为流动相,流速1.0 mL.min-1,在紫外波长为360 nm处检测。血浆样品需经乙腈沉淀蛋白,离心后取上清与DNPH发生衍生化反应,正己烷-乙酸乙酯(5∶1,v/v)萃取衍生化产物ACH-DNPH,进行高效液相色谱测定。结果:乙醛在0.05~10.00μg.mL-1浓度范围内线性关系良好(r=0.9999),检测限为0.01μg.mL-1,定量限为0.05μg.mL-1;高、中、低3个浓度的相对回收率为102.7%~109.0%;日内RSD为1.6%~4.3%,日间RSD为3.3%~6.3%。结论:本法可用于大鼠体内乙醇代谢动力学研究。 Objective:To establish a method for determination of acetaldehyde (ACH) in rat plasma by HPLC Methods:With butyl aldehyde - 2,4 - dinitrophenylhydrazine ( BUH - DNPH) as the internal standard, ACH - DN- PH was detected by UV detector at the wavelength of 360 nm with the ZORBAX Eclipse XDB -C18 (250 mm ×4.6 mm, 5 μm) column. The mobile phase was methanol - acetonitrile - water ( 25: 35: 40, v/v/v) and the flow rate was 1.0 mL ·min^-1. The plasma samples were treated with acetonitrile to precipitate proteins. After centrifugation, the supernatant was reacted with DNPH reagent. The derived acetaldehyde was then isolated by n-hexane - acetidin (5 : 1, v/v) and quantitated by high performance liquid chromatography. Results: The assay linearity of ACH was con- firmed over the range of 0.05 - 10. 00 μg·mL^-1 (r = 0. 9999). The limit of detection was 0.01 μg·mL^-1and the limit of quantitation was 0.05 μg·mL^-1. The relative recoveries at high, medium and low concentrations were with- in 102.7% - 109.0% ,and the RSD of intra - day and inter - day assays were 1.6% -4.3% and 3.3% -6.3% , respectively. Conclusion:The method is suitable for the pharmacokinetic research of alcohol in rats.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第12期2132-2136,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 乙醛 血浆样品 2 4-二硝基苯肼(DNPH)内标 衍生化 代谢动力学研究 高效液相色谱法 acetaldehyde plasma 2,4 - dinitrophenylhydrazine ( DNPH ) derivatization pharmacokinetic re- search HPLC
  • 相关文献

参考文献13

  • 1Drummer S,Hauser WE Jr,Remington JS.Antabuse-like effect of beta-lactam antibiotics.Alcohol-Medline Plus Health Inf,1980,303(24):1417.
  • 2Matsubara T.Safety evaluation and drug development based on biological fate of drugs-efforts made to overcome drug interaction in drug development.Drug Metab Pharmacokinet,2002,17(5):379.
  • 3Sharma V,Sharma A,Kumar V,et al.Disulfiram-like reaction with ornidazole.J Postgrad Med,2009,55(4):292.
  • 4Visap JP,Tillonen JS,Kaihovaara PS,et al.Lack of disulfiram-like reaction with metronidazole and ethanol.Ann Pharmacother,2002,36(6):971.
  • 5Kozutsumi D,Arita M,Kawashima A,et al.An improved method for acetaldehyde determination in blood by high-performance liquid chromatography and solid-phase extraction.J Chromatogr Sci,2002,40(9):477.
  • 6Possanzini M,Di Palo V.Simultaneous determination of HCHO,CH3CHO and O(x) in ambient air by hydrazine reagent and HPLC.Ann Chim,2003,93(1-2):149.
  • 7Oliva-Teles MT,Paiga PP,Delevue-Matos CM,et al. Determination of free formaldehyde in foundry resins as its 2,4-dinitrophenylhydrazone by liquid chromatography.Anal Chim Acta,2002,467:97.
  • 8Takayanagi M,Goto S,Kokubo Y,et al.Determination of acetaldehyde in human blood by high-performance liquid chromatography using fluorometry.Chem Pharm Bull(Tokyo),1989,37(1):200.
  • 9Fukunaga T,Yamamoto H,Tanegashima A.Determination methods for human blood acetaldehyde.Nihon Arukoru Yakubutsu Igakkai Zasshi,1998,33(3):190.
  • 10Nuutinen H,Lindros KO,SalaspuroM.Determinants of blood acetaldehyde level during ethanol oxidation in chronic alcoholics.Alcohol Clin Exp Res,1983,7(2):163.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部